Retrospective Study of Pegaspargase, Gemicitabine, Oxaliplatin and Dexamethasone (Peg-GemOD) as a First-Line Therapy for Advanced-Stage Extranodal NK/T Cell Lymphoma-Reference-Cited by-同舟云学术

Retrospective Study of Pegaspargase, Gemicitabine, Oxaliplatin and Dexamethasone (Peg-GemOD) as a First-Line Therapy for Advanced-Stage Extranodal NK/T Cell Lymphoma

Published:2016-03-19 Issue:1 Volume:33 Page:74-81
ISSN:0971-4502
Container-title:Indian Journal of Hematology and Blood Transfusion
language:en
Short-container-title:Indian J Hematol Blood Transfus

Author:

Yao Yi-yun,Tang Yong,Zhuang Yan,Zou Li-fang,Dou Hong-ju,Wang Lei,Zhu Qi

Funder

Shanghai Committee of Science and Technology

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12288-016-0670-2.pdf

Reference20 articles.

1. Aozasa K, Takakuwa T, Hongyo T et al (2008) Nasal NK/T-cell lymphoma: epidemiology and pathogenesis. Int J Hematol 87(2):110–117

2. Wang L, Wang ZH, Chen XQ et al (2013) First-line combination of gemcitabine, oxaliplatin, and l-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE/IIE extranodal natural killer/T-cell lymphoma. Cancer 119(2):348–355

3. Yamaguchi M, Tobinai K, Oguchi M et al (2012) Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211. J Clin Oncol 30(32):4044–4046

4. Yamaguchi M, Kita K, Miwa H et al (1995) Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer 76(11):2351–2356

5. Jaccard A, Gachard N, Marin B et al (2011) GELA and GOELAMS Intergroup. Efficacy of l-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood 117(6):1834–1839

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel prognostic index for extranodal natural killer/T-cell lymphoma in the era of pegaspargase/L-asparaginase;Future Oncology;2024-07-23

2. Treatment and Prognosis of Newly Diagnosed Advanced-Stage Extranodal Natural Killer/T-Cell Lymphoma: A Single-Center Real-World Study across Two Decades;Chemotherapy;2023-11-20

3. Up‐front autologous hematopoietic stem cell transplantation after first complete remission improved prognosis of advanced extra‐nodal NKT cell lymphoma: A multicenter real‐world study in China;European Journal of Haematology;2023-03-28

4. The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study;Cancer Management and Research;2021-02

5. Defining the toxicity of current regimens for extranodal NK/T cell lymphoma: a systematic review and metaproportion;Expert Review of Anticancer Therapy;2018-11-23